• 1
    Sherman KE, Freeman S, Harrison S, Andron L. Prevalence of antibodies to hepatitis C virus in patients infected with the human immunodeficiency virus. J Infect Dis 1991; 163:414415.MEDLINE
  • 2
    Rumi MG, Colombo M, Grigeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112:279297.
  • 3
    Hayashi PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, Zeldis JB. Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus. J Med Virol 1991; 33:177180.MEDLINE
  • 4
    Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853860.MEDLINE
  • 5
    Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999; 30:10541058.MEDLINE
  • 6
    Soto B, Sanchez-Quijano A, Rodrigo L, Del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:15.MEDLINE
  • 7
    Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, Dusheiko M, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997; 350:14251431.MEDLINE
  • 8
    Brau N, Leaf HL, Wieczorek RL, et al. Severe hepatitis in three AIDS patients treated with indinavir. Lancet 1997; 349:924925.MEDLINE
  • 9
    Matsuda J, Gohchi K. Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir. Lancet 1997; 350:364.MEDLINE
  • 10
    Vergis E, Paterson DL, Singh N. Indinavir-associated hepatitis in patients with advanced HIV infection. Int J STD AIDS 1998; 9:53.MEDLINE
  • 11
    Karras A, Rabian C, Zylberberg H, Hermine O, Duchatelle V, Durand F, Valla D, et al. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy. AIDS 1998; 12:827829.MEDLINE
  • 12
    Arribas JR, Ibanez C, Ruiz-Antoran B, Pena JM, Esteban-Calvo C, Frias J, Vazquez JJ, et al. Acute hepatitis in HIV-infected patients during ritonavir treatment. AIDS 1998; 12:17221724.MEDLINE
  • 13
    John M, Flexman J, French MA. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS 1998; 12:22892293.MEDLINE
  • 14
    Zylberberg H, Pialoux G, Carnot F, Landau A, Bréchot C, Pol S. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy. Clin Infect Dis 1998; 27:12551258.MEDLINE
  • 15
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825832.MEDLINE
  • 16
    The METAVIR cooperative group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994; 20:1520.MEDLINE
  • 17
    Bedossa P, Poynard T for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24:289293.MEDLINE
  • 18
    Sous la direction de Hseligman M, Alexandre JP: Traitement antirétroviraux. In: Médecine et Sciences, Flammarion (ed). Prise en charge des personnes atteintes par le VIH. Rapport au ministre, goupe d'experts présidé par Dormont J, rapport 1996. Paris: Flammarion et Ministère de l'Emploi et de la Solidarité, 1996;185220.
  • 19
    Stratégies d'utilisation des antirétrauviraux dans l'infection par le VIH. Recommendations du groupe d'experts cliniciens et virologues, rapport 1998 sous la direction de Dormont J. Flammarion et Ministère de l'Emploi et de la Solidarité, 1998:1162.
  • 20
    Sous la direction de Hoen B, Raffy F: Traitement antirétroviral. In: Médecine et Sciences, Flammarion (ed). Prise en charge thérapeutique des personnes infectées par le VIH. Recommandations du groupe d'experts, rapport 1999 sous la direction de Delfraissy JF. Paris: Flammarion et Ministère de l'Emploi et de la Solidarité, 1999;5184.
  • 21
    Saves M, Vandentorren S, Daucourt V, Marimoutou C, Dupont M, Couzigou P, et al. Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations therapy Aquitaine Cohort, France, 1996-1998. AIDS 1999; 13:115121.
  • 22
    Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Elevated liver enzymes following initiation of antiretroviral therapy. JAMA 2000; 283:25262527.MEDLINE
  • 23
    Lonergan JT, Behling C, Pfander H, Hassanein TI, Mathews WC. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis 2000; 31:162166.MEDLINE
  • 24
    Bachen MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. J Clin Invest 1992; 89:1927.MEDLINE
  • 25
    Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328:18281835.MEDLINE
  • 26
    Allen JB, Wong HI, Guyre PM, Simon GI, Walh SM. Association of circulating receptor FcyRIII-positive monocytes in AIDS patients with elevated levels of transforming grow factor-β. J Clin Invest 1991; 87:17731779.MEDLINE
  • 27
    Pacifici R, Di Carlo S, Bacosi A, Pichini S, Zuccaro P. Cytokine production in saquinavir treated mice. Int J Immunopharmac 1997; 19:243248.